Chair(s) | TBD |
---|---|
Speaker(s) | A disease-modifying effect in the treatment of IgA nephropathy Jonathan Barratt (Leicester General Hospital) |
Chair(s) | Sung Gyun Kim (Hallym University Sacred Heart Hospital) |
---|---|
Speaker(s) | Beyond Glucose Control: Empagliflozin in Renal and Cardiovascular Management TBD |
Chair(s) | Eun Hui Bae (Chonnam National University Hospital) |
---|---|
Pannel(s) |
PANNEL DISCUSSION
Evidence-based Strategies for Optimized CKD Management in Patients with T2D Non-steroidal MRA in Clinical Pratice:Who, When and How? |
ASK THE EXPERTS
Practical Considerations in the Management of Patients with CKD and T2D with Non-steroidal MRAs Rajiv Agarwal (Indiana University School of Medicine) Bo Xu (Zhongshun Hospital Xiamen University) Yingyos Avihingsanon (Chulalongkorn University) |
Speaker(s) | TBD Jonathan Barratt (University of Leicester),David Jayne (University of Cambridge) ,Ming-hui Zhao (Peking University First Hospital) |
---|
Chair(s) | Dukhee Kang (Ewha womans University seoul Hospital) |
---|---|
Speaker(s) | ADPKD introduction and Clinical implication of Tolvaptan Hyunsuk Kim (Hallym University Chuncheon Sacred Heart Hospital) |
Speaker(s) | Recent recommendations for management of ANCA-associated vasculitis Tae Hyun Ban (The Catholic University of Korea, Eunpyeong St. Mary's Hospital) |
---|
Speaker(s) | Trends and Prospects of AI-medical devices leveraging Bio-signals Sunghoon Joo (VUNO Inc. CTO), Seokhun Lim (VUNO Inc. CSO) |
---|